Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
FesariusTherapeutics secures $20M in an oversubscribed Series A round, led by Jefferson Life Sciences, to advance its innovative DermiSphere technology.
Amount Raised
$20 Million
Round Type
Series A
Investors
Description
FesariusTherapeutics has successfully closed a $20 million Series A financing round. The round was led by Jefferson Life Sciences, alongside investors like Johnson & Johnson Innovation and NY Ventures. This funding will help accelerate the company's commercial infrastructure and support clinical trials for its flagship product, DermiSphere™. The investment marks a significant milestone for Fesarius as it builds commercial momentum in U.S
Fundz sees it the moment FesariusTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansFesariusTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.